---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-002315"
form_type: "8-K/A"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2025-04-18T23:59:59+00:00"
generated_at: "2026-05-23T10:57:13.248271+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology ends merger talks with Renovaro; no binding agreement signed

## Summary
- POAI decided to discontinue discussions with RENB regarding the proposed merger.
- POAI states it never entered into a merger agreement; RENB's April 4 press release claims were misrepresentations.
- The letter of intent with RENB expired on March 31, 2025; POAI has no further obligations.
- POAI reaffirms commitment to its AI-driven drug discovery and drug development business.

## SEC filing metadata
- accession: 0001171843-25-002315
- form_type: 8-K/A
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2025-04-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184325002315/0001171843-25-002315-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184325002315/f8ka_041825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-002315
- JSON: https://secwatch.observer/filing/0001171843-25-002315.json
- Plain text: https://secwatch.observer/filing/0001171843-25-002315.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.